BRCA1 and breast cancer: We show that reducing Sox11 levels in the Brca1-deficient mammary tumour (Brca1.3) has similar effects on proliferation, stem cell activity and expression of lineage markers to those observed in studies using embryonic mammary progenitor cells (eG2M5).